Skip to main content

Month: August 2020

Iterum Therapeutics Commences Rights Offering

DUBLIN, Ireland and CHICAGO, Aug. 11, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that it has commenced its previously disclosed rights offering. Pursuant to the rights offering, the Company and Iterum Bermuda Therapeutics Limited, the Company’s wholly-owned subsidiary (“Iterum Bermuda”), are distributing, at no charge to the holders of record of the Company’s outstanding ordinary shares as of 5:00 p.m. Eastern Time on August 5, 2020, and to eligible warrant holders, one non-transferable subscription right for each ordinary share owned (or deemed owned in the case of eligible warrant...

Continue reading

Senvest Capital Inc. Announces Acceptance by TSX of Normal Course Issuer Bid

MONTREAL, Aug. 11, 2020 (GLOBE NEWSWIRE) — Senvest Capital Inc. (the “Corporation”) (TSX: SEC) announced today the acceptance by the Toronto Stock Exchange (the “TSX”) of the Corporation’s Notice of Intention to make a normal course issuer bid (the “NCIB”). Pursuant to the NCIB, the Corporation proposes to purchase, from time to time, if considered advisable, up to an aggregate of 70,000 of its common shares, being approximately 2.67% of its 2,623,224 issued and outstanding common shares as of August 1, 2020, through the facilities of the TSX or through various eligible alternative trading systems. However, due to the historically low volume of trading of its common shares on the TSX, the Corporation advises that actual purchases under the NCIB may in fact be significantly less than 70,000 shares. Purchases may commence on August...

Continue reading

Senvest Capital Inc. annonce que la TSX a approuvé son offre publique de rachat dans le cours normal des activités

MONTRÉAL, 11 août 2020 (GLOBE NEWSWIRE) — Senvest Capital Inc. (la « Société ») (TSX : SEC) a annoncé aujourd’hui que la Bourse de Toronto (la « TSX ») a accepté son avis d’intention de présenter une offre publique de rachat dans le cours normal des activités (l’« Offre »). Aux termes de l’Offre, la Société propose d’acheter, de temps à autre et si elle le juge à propos, jusqu’à 70 000 de ses actions ordinaires au total, soit environ 2,67% de ses 2 623 224 actions ordinaires émises et en circulation en date du 1er août 2020, par l’entremise de la TSX ou de plateformes de négociation parallèles admissibles, le cas échéant. Toutefois, en raison du volume historiquement bas des négociations de ses actions ordinaires à la TSX, la Société informe que le niveau des achats réels aux termes de l’Offre pourrait, en fait, être considérablement...

Continue reading

Teledyne Princeton Instruments and Teledyne Acton Optics’ UV lenses and mirrors on board NASA’s Mars Rover Perseverance

TRENTON, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) — Teledyne Princeton Instruments, a Teledyne Technologies [NYSE:TDY] company,  and world-renowned manufacturer of scientific imaging and spectroscopy equipment, is pleased to announce that Teledyne Acton Optics UV lenses and mirrors were incorporated into the SHERLOC UV Spectrometer module, a remote based sensing instrument, on board NASA’s Mars Rover Perseverance, which launched on July 30th at 07.50 Eastern Time.NASA’s Mars 2020 mission is the next instalment of the long-term effort to robotically explore Mars. This mission addresses current high-priority scientific goals, including trying to answer the question of whether there are signs of past microbial life on the planet.By studying an astrobiologically relevant ancient environment on Mars, the Perseverance aims to investigate...

Continue reading

Akers Biosciences Announces $6.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Thorofare, New Jersey, Aug. 11, 2020 (GLOBE NEWSWIRE) — Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 1,207,744 shares of the Company’s common stock, at a purchase price of $5.67 per share, in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about August 13, 2020, subject to the satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.The gross proceeds to the Company from this offering are expected to be approximately $6.8 million, before deducting the placement agent’s fees and other offering expenses payable by the Company.The...

Continue reading

BTHR’s Shadow Gaming Announces the Results of August 9, 2020 Masters Knights Duel #1, its 2nd Minion Master Tournament

TAMPA, FL, Aug. 11, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Sports Venues of Florida, Inc., (OTC: BTHR) (“BTHR” or the “Company”) an emerging leader in the eSports, youth sports, and family sports entertainment markets, announced it has the results of August 9, 2020, Minion Masters Knights Duel #1 tournament.This is Minion Masters’s second event sponsored by Shadow Gaming and it has been a total success. The tournament kicked off with over sixty players going head-to-head in 1v1 matches. Katt came ready to defend his title as the reigning Shadow Gaming Minion Masters Champion, but was knocked into the Loser’s backed by JF in round 4!Not to be stopped, Katt fought his way back for a shot at the crown by defeating Nikola, CroakerX, DragoN, and Nerzl, finding himself back against JF in the SemiFinals!JF played...

Continue reading

Epazz Engages PCAOB Auditor in Order to Uplist to the OTCQB; Releases Contact Tracing Update to DeskFlex for Covid-19 Back to School

DeskFlex’s Desk and Room Scheduling System help prevent the onset of COVID-19 infection on college campuses with its contact tracing toolCHICAGO, IL, Aug. 11, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Epazz Inc. DeskFlex (OTC: EPAZ), a cloud-computing software provider company, announced today that it has engaged a PCAOB Auditor to audit 2018 and 2019 financials. Once the audit is complete, the company will uplist to OTCQB to provide more substantial transparency to investors. DeskFlex desk and room scheduling system releases its newest software feature, the Contact Tracing tool to prevent and contain a possible outbreak in the workplace, schools, and campuses. DeskFlex’s Contact Tracing software screens students, faculty, employees, and registered users for symptoms of COVID infection upon logging into the system. It sends...

Continue reading

Post Holdings Announces Commencement of Senior Notes Offering

ST. LOUIS, Aug. 11, 2020 (GLOBE NEWSWIRE) — Post Holdings, Inc. (NYSE:POST) (the “Company” or “Post”) today announced it intends to commence a private offering to eligible purchasers, subject to market and other conditions, of $300.0 million in aggregate principal amount of 4.625% senior notes due 2030 (the “Notes”).The Notes are being offered as additional notes under an existing indenture pursuant to which the Company previously issued $1,250.0 million in aggregate principal amount of 4.625% senior notes due 2030 (the “Existing Notes”). The Notes to be issued in this offering will vote together with and will constitute part of the same series as the Existing Notes. The Notes will be unsecured unsubordinated obligations of the Company and will be guaranteed by the Company’s material domestic subsidiaries (other than certain excluded...

Continue reading

BridgeBio Pharma, Inc. Reports Second Quarter 2020 Financial Results and Business Update

-Initiated four clinical trials, progressed its additional 11 ongoing clinical trials and submitted three INDs to FDA since the beginning of 2020-Strategic collaboration with Perceptive Advisors-founded company LianBio expands BridgeBio’s global reach into China-Ended quarter with $840.9 million in cash, cash equivalents and marketable securitiesSAN FRANCISCO, Aug. 11, 2020 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO), a clinical-stage biopharmaceutical company focused on genetic diseases and cancers with clear genetic drivers, today reported its financial results for the second quarter ending June 30, 2020 and provided an update on the company’s operations.Since the beginning of 2020, BridgeBio has initiated four company-sponsored clinical trials, progressed its additional 11 ongoing clinical trials, submitted three Investigational...

Continue reading

Willscot Mobile Mini Holdings Announces $500 Million Senior Secured Notes Offering

PHOENIX, Aug. 11, 2020 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC), a North American leader in modular space and portable storage solutions, today announced that its indirect subsidiary, Williams Scotsman International, Inc. (“WSII”), plans to offer $500 million in aggregate principal amount of senior secured notes due 2028 (the “Notes”). WillScot Mobile Mini intends to use the offering proceeds to redeem all $441 million in aggregate principal amount remaining outstanding of WSII’s 6.875% senior secured noted due 2023 (the “2023 Notes”), after giving effect to the redemption of 10% of the aggregate principal amount of the 2023 Notes, as announced on July 27, 2020. This announcement does not form part of or constitute a notice of redemption with respect to the 2023...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.